Asier Unciti-Broceta

Personal Chair of Medicinal Chemistry - Innovative Therapeutics

Background

Asier Unciti-Broceta received his PhD in Medicinal Chemistry from the Universidad of Granada (Spain) in 2004 and completed his postdoctoral training in the fields of cell delivery and chemical biology in the School of Chemistry of the University of Edinburgh. He joined the Cancer Research UK Edinburgh Centre as a group leader in 2010, where he established the Innovative Therapeutics Lab in 2010 (first chemistry lab of the Institute), and promoted to Reader in 2015. Asier is an Elected Member of the RSE Young Academy of Scotland, Associate Editor of Frontiers in Chemistry and Editorial Board Member of Scientific Reports. He is PI of Edinburgh Drug Discovery and Chemistry Director of the Edinburgh Cancer Discovery Unit. Among his most recent awards highlight the CRUK Pioneer Award 2015, the EPSRC Healthcare Technology Challenge Award 2015 and the RSE/Patrick Neill Medal 2016.

Qualifications

2015-now Reader in Pharmaceutical Chemistry, ECRC, IGMM, UoE (UK) 2010-15 Group Leader / Academic Fellow, ECRC, IGMM, UoE (UK) 2008-10 SE Research Fellow, School of Chemistry, UoE (UK) 2005-08 Postdoc, School of Chemistry, University of Edinburgh (UoE, UK) 2001-04 PhD in Medicinal Chemistry, University of Granada (Spain)

View all 60 publications on Research Explorer